£495.00

It has never been this cheap. We have no record of a lower price.

£495 today · cheaper than every other day in the last 3 months

The 2023-2028 Outlook for Schizophrenia Drugs in Japan

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 85 days · 85 data points (no recent data)

Historical
Generating forecast…
£495.00 £470.25 £480.15 £490.05 £499.95 £509.85 £519.75 12 August 2026 02 September 2026 23 September 2026 14 October 2026 04 November 2026
View at Amazon ↗

Price data checked 6 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 85 days • 1 price levels

Days at Price
85 days 0 21 43 64 85 £495 Days at Price

Price Analysis

Most common price: £495 (85 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 85 days

Description

This study covers the latent demand outlook for schizophrenia drugs across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for schizophrenia drugs. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of schizophrenia drugs as including all commonly understood products falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Alkermes, Allergan, AstraZeneca, Bristol-Myers Squibb, Chapter Summary -, Eli Lilly, H. Lundbeck, Janssen Pharmaceuticals, Johnson & Johnson, Otsuka Pharmaceutical Company, Pfizer, Sumitomo Dainippon Pharma, and Vanda Pharmaceuticals. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
28 November 2022
Listed Since
08 December 2022

Similar Products You Might Like

The 2023-2028 Outlook for Schizophrenia Therapeutics in Japan
99% match

The 2023-2028 Outlook for Schizophrenia Therapeutics in Japan

£495.00 26 Sep 2026
The 2023-2028 Outlook for Schizophrenia Treatments in Japan
99% match

The 2023-2028 Outlook for Schizophrenia Treatments in Japan

£495.00 30 Oct 2026
The 2023-2028 Outlook for Antipsychotic Drugs for Schizophrenia in Japan
99% match

The 2023-2028 Outlook for Antipsychotic Drugs for Schizophrenia in Japan

£495.00 04 Nov 2026
The 2023-2028 Outlook for First Generation Antipsychotic Drugs for Schizophrenia in Japan
99% match

The 2023-2028 Outlook for First Generation Antipsychotic Drugs for Schizophrenia in Japan

£495.00 04 Nov 2026
Schizophrenia Drugs US Outlook 2023-2028 Market Study
99% match

Schizophrenia Drugs US Outlook 2023-2028 Market Study

£520.00 08 Nov 2026
Schizophrenia Treatment Outlook 2023-2028 - US Market Study
98% match

Schizophrenia Treatment Outlook 2023-2028 - US Market Study

£520.00 08 Nov 2026
US Antipsychotic Drug Outlook for Schizophrenia 2023-2028
98% match

US Antipsychotic Drug Outlook for Schizophrenia 2023-2028

£520.00 28 Oct 2026
2023-2028 Antipsychotic Drug Outlook - US Zip Code Study
98% match

2023-2028 Antipsychotic Drug Outlook - US Zip Code Study

£490.00 21 Oct 2026
Schizophrenia: Effects on Daily Life (DVD) (Concept Media: Educational Videos)
97% match

Schizophrenia: Effects on Daily Life (DVD) (Concept Media: Educational Videos)

Cengage Learning

£302.40 20 Oct 2026
Schizophrenia Treatment - The New Facets
96% match

Schizophrenia Treatment - The New Facets

IntechOpen

£101.15 11 Sep 2026
Cognitive Functioning in Schizophrenia: Leveraging the RDoC Framework: 63 (Current Topics in Behavioral Neurosciences, 63)
96% match

Cognitive Functioning in Schizophrenia: Leveraging the RDoC Framework: 63 (Current Topics in Behavioral Neurosciences, 63)

Springer

£83.21 12 Oct 2026
Schizophrenie: Dopaminrezeptoren und Neuroleptika
96% match

Schizophrenie: Dopaminrezeptoren und Neuroleptika

Springer

£64.22 17 Sep 2026
Schizophrenia in the 21st Century
96% match

Schizophrenia in the 21st Century

IntechOpen

£114.00 27 Sep 2026
Schizophrenia: A Contemporary Introduction (Routledge Introductions to Contemporary Psychoanalysis)
96% match

Schizophrenia: A Contemporary Introduction (Routledge Introductions to Contemporary Psychoanalysis)

Routledge

£138.43 19 Sep 2026
Schizophrenie:: Interaktionsprozesse Und Emotionales Klima in Der Familie: 308 (Europaeische Hochschulschriften / European University Studie)
96% match

Schizophrenie:: Interaktionsprozesse Und Emotionales Klima in Der Familie: 308 (Europaeische Hochschulschriften / European University Studie)

Peter Lang Gmbh, Internationaler Verlag Der Wissenschaften

£72.35 20 Oct 2026
A Phenomenological Interpretation of Schizophrenia: Subjectivation, Framework and Perspective
96% match

A Phenomenological Interpretation of Schizophrenia: Subjectivation, Framework and Perspective

Springer

£80.65 22 Sep 2026
New Approaches to the Management and Diagnosis of Schizophrenia
96% match

New Approaches to the Management and Diagnosis of Schizophrenia

IntechOpen

£119.00 24 Sep 2026
Schizophrenia: An Integrated View Albert Benzon Symposium 38: v. 38 (Alfred Benzon Symposium Series)
96% match

Schizophrenia: An Integrated View Albert Benzon Symposium 38: v. 38 (Alfred Benzon Symposium Series)

Wiley-Blackwell

Price unavailable
World Outlook 2025-2030: Psychiatric and Substance Abuse Hospitals
96% match

World Outlook 2025-2030: Psychiatric and Substance Abuse Hospitals

Price unavailable
Negative and Cognitive Symptoms in Schizophrenia (Comprehensive Approach to Psychiatry, 3)
96% match

Negative and Cognitive Symptoms in Schizophrenia (Comprehensive Approach to Psychiatry, 3)

Springer

£95.74 25 Sep 2026
Self Fragmentation and Integration in Schizophrenia - Volume 1
96% match

Self Fragmentation and Integration in Schizophrenia - Volume 1

Nova Science Publishers Inc

£101.67 17 Oct 2026
Neuroproteomics as a Tool for Understanding Schizophrenia: 1400 (Advances in Experimental Medicine and Biology, 1400)
96% match

Neuroproteomics as a Tool for Understanding Schizophrenia: 1400 (Advances in Experimental Medicine and Biology, 1400)

Springer

£118.60 19 Sep 2026
Psychotherapy of Preoedipal Conditions: Schizophrenia and Severe Character Disorders: Schizophrenia and Severe Character Disorders
96% match

Psychotherapy of Preoedipal Conditions: Schizophrenia and Severe Character Disorders: Schizophrenia and Severe Character Disorders

Jason Aronson

£69.60 05 Oct 2026
Ethical and Clinical Complexities in the Treatment of Schizophrenia: Liberty or Life
96% match

Ethical and Clinical Complexities in the Treatment of Schizophrenia: Liberty or Life

Cambridge University Press

£48.02 07 Oct 2026